Table 6. Peri-operational systemic condition between procedures in per-protocol population.
| MIPDO (N=49) | Surgical (N=51) | P valuea | ||||||
|---|---|---|---|---|---|---|---|---|
| Baseline | Dischargeb | P value | Baseline | Discharge | P value | |||
| WBC (109/L) | 8.06±2.35 | 8.50±2.83 | 0.26 | 8.92±2.71 | 10.86±3.39 | <0.001 | <0.001 | |
| Hb (g/L) | 119.46±12.23 | 108.94±13.49 | <0.001 | 120.54±16.23 | 105.58±13.87 | <0.001 | 0.22 | |
| PLT (109/L) | 299 (260 to 331) | 249 (188 to 313) | <0.001 | 302 (255 to 366) | 210 (167 to 238) | <0.001 | 0.002 | |
| ALT (IU/L) | 14 (11 to 19) | 12 (9 to 17) | 0.005 | 16 (14 to 21) | 15 (13 to 18) | 0.03 | 0.11 | |
| AST (IU/L) | 31 (27 to 38) | 28 (22 to 34) | 0.001 | 32 (26 to 38) | 32 (27 to 42) | 0.59 | 0.002 | |
| CK-MB (IU/L) | 21 (4 to 29) | 13 (10 to 15) | <0.001 | 20 (6 to 25) | 12 (10 to 16) | <0.001 | 0.23 | |
| CK (IU/L) | 74 (49 to 102) | 107 (66 to 160) | <0.01 | 91 (62 to 120) | 267 (145 to 407) | <0.001 | <0.001 | |
| LDH (IU/L) | 240 (96 to 270) | 242 (169 to 313) | 0.001 | 219 (124 to 264) | 340 (282 to 408) | <0.001 | <0.001 | |
| Scr (μmol/L) | 28.7 (25.2 to 32.3) | 27.3 (22.9 to 32.8) | 0.09 | 29.0 (22.7 to 37.6) | 28.8 (21.9 to 36.7) | 0.61 | 0.42 | |
| BUN (mmol/L) | 4.01±1.23 | 4.21±1.25 | 0.24 | 3.68±1.09 | 5.00±1.68 | <0.001 | 0.005 | |
WBC, white blood cell count; Hb, hemoglobin; PLT, platelet count; ALT, alanine transaminase; AST, aspartate transaminase; CK-MB, creatine kinase-MB; CK, creatine kinase; LDH, lactate dehydrogenase; Scr, serum creatinine; BUN, blood urea nitrogen. acomparison of variation from baseline to discharge between groups; bmeasured at 3-day after procedure.